Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock

被引:29
|
作者
von Dobschuetz, E
Hoffmann, T
Messmer, K
机构
[1] Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-81366 Munich, Germany
[2] Maria Theresia Klin, Munich, Germany
关键词
acute pancreatitis; blood substitute; hemoglobin solution; leukocyte-endothelium interaction; transfusion;
D O I
10.1097/00000542-199912000-00029
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Microvascular reperfusion failure of splanchnic organs is a crucial hallmark in organ damage induced by hemorrhagic shock, which should be prevented by a resuscitation solution. Because the vasoactive properties of the hemoglobin-based oxygen carrier diaspirin cross-linked hemoglobin (DCLHb) could adversely influence restoration of pancreatic capillary perfusion during resuscitation, the authors investigated its effects on the microcirculation of the rat pancreas in comparison with whole blood and 6% hydroxyethylstarch resuscitation from severe hemorrhagic shock. Methods: Twenty-eight pentobarbital-anaesthetized rats were bled to a mean arterial pressure (MAP) of 40 mmHg and maintained at this level for 1 h, Using an intravital microscope, mean arterial pressure, the length of erythrocyte-perfused pancreatic capillaries per observation area (functional capillary density), the adherence of leukocytes in postcapillary venules, and pancreatic Lipid peroxidation, measured as thiobarbituric acid-reactive material in pancreatic tissue, were determined in animals resuscitated by volumes of hydroxyethylstarch, DCLHb, and whole blood (WB) equivalent to the shed blood volume or in control animals without shock induction for a period of 2 h after resuscitation. Results: Compared with control animals (366 +/- 28 cm(-1)), animals resuscitated with DCLHb (294 +/- 45 cm(-1)), WE (306 +/- 11 cm(-1)), and hydroxyethylstarch (241 +/- 34 cm(-1)) showed a significant reduction of functional capillary density after 2 h of resuscitation. DCLHb was as effective as WB and superior to hydroxyethylstarch in restoring functional capillary density and mean arterial pressure. Leukocyte adherence in postcapillary venules was not enhanced by DCLHb (369 +/- 148/mm(2)) infusion when compared with hydroxyethylstarch (615 +/- 283/mm(2)) and WB-treated (510 +/- 415/mm(2)) animals. Lipid peroxidation of pancreatic tissue was significantly elevated after treatment with both oxygen-carrying solutions compared with hydroxyethylstarch. Conclusion: DCLHb is as effective as WE for preservation of the pancreatic microcirculation.
引用
收藏
页码:1754 / 1762
页数:9
相关论文
共 50 条
  • [1] Diaspirin cross-linked hemoglobin (DCLHb) restores pancreatic microcirculatory failure after hemorrhagic shock.
    Von Dobschuetz, E
    Hoffmann, T
    Messmer, K
    SHOCK, 1999, 11 : 14 - 14
  • [2] RESUSCITATION WITH DIASPIRIN CROSS-LINKED HEMOGLOBIN IN A PIG MODEL OF HEMORRHAGIC-SHOCK
    DUNLAP, E
    FARRELL, L
    NIGRO, C
    ESTEP, T
    MARCHAND, G
    BURHOP, K
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1995, 23 (01): : 39 - 61
  • [3] Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blond, or hetastarch - Discussion
    Peitzman, AB
    Cryer, HG
    Hirsch, EF
    Kramer, GC
    Osler, TM
    Yukioka, T
    Hauser, C
    McSwain, NE
    Shapiro, MB
    Lewis, FR
    Conhaim, RL
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1997, 42 (03): : 412 - 414
  • [4] Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion
    Pape, A
    Kleen, M
    Kemming, G
    Meisner, F
    Meier, J
    Habler, O
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (10) : 1328 - 1337
  • [5] The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents
    Edward P. Sloan
    Intensive Care Medicine, 2003, 29 : 347 - 349
  • [6] The effects of diaspirin cross-linked hemoglobin in sepsis
    Mourelatos, MG
    Enzer, N
    Ferguson, JL
    Rypins, EB
    Burhop, KE
    Law, WR
    SHOCK, 1996, 5 (02): : 141 - 148
  • [7] Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock - A randomized controlled efficacy trial
    Sloan, EP
    Koenigsberg, M
    Gens, D
    Cipolle, M
    Runge, J
    Mallory, MN
    Rodman, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (19): : 1857 - 1864
  • [8] The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents
    Sloan, EP
    INTENSIVE CARE MEDICINE, 2003, 29 (03) : 347 - 349
  • [9] Diaspirin cross-linked hemoglobin improves oxygen extraction capabilities in endotoxic shock
    Creteur, J
    Zhang, HB
    De Backer, D
    Sun, QH
    Vincent, JL
    JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (04) : 1437 - 1444
  • [10] Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock
    von Dobschuetz, E
    Hutter, J
    Hoffmann, T
    Messmer, K
    ANESTHESIOLOGY, 2004, 100 (06) : 1484 - 1490